Relay Therapeutics, Inc. ($RLAY)
Filing Information
| Accession Number | 0001193125-26-029412 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 29, 2026 |
| Document Date | Jan 27, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
14,032
Total Value
$103,445.44
P&L
+231.4% (+$6,878.48)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Corporate Development Officer | Common Stock | โ | Dec 31, 2025 | Grant/Award | 994 | $2.99 | $2,972.06 | 338,463 | Direct | โ | View Details | |
Chief Corporate Development Officer | Common Stock | โ | Jan 27, 2026 | Sale | 11,684 | $7.62 | $89,032.08 | 277,964 | Direct | โ | View Details | |
Chief Corporate Development Officer | Common Stock | โ | Jan 28, 2026 | Sale | 1,354 | $8.45 | $11,441.30 | 276,610 | Direct | โ | View Details |